Form 4 for KPTI Karyopharm Therapeutics Inc.
Accepted 2023-09-05 00:00:00 ET · period of report 2023-09-01 · accession 0001209191-23-048162 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-05 | 2023-09-01 | KPTI | Mason Michael | EVP, CFO, Treas | S - Sale | $1.33 | -6,913 | 237.8K | -3% | -$9,194 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-01 | S | D | 6,913 | $1.33 | 237,817 | D | — | — |